vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与Weave Communications, Inc.（WEAV）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Weave Communications, Inc.的1.2倍（$75.5M vs $63.4M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 17.0%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $5.1M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 15.9%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
Weave Communications, Inc.是面向中小商家的一体化客户互动与通信平台提供商，产品涵盖云电话系统、预约排期、支付处理、评价管理、短信工具等，主要服务美加地区牙科、医疗、健身等本地服务领域的经营主体。
PBYI vs WEAV — 直观对比
营收规模更大
PBYI
是对方的1.2倍
$63.4M
营收增速更快
PBYI
高出10.7%
17.0%
自由现金流更多
PBYI
多$9.3M
$5.1M
两年增速更快
PBYI
近两年复合增速
15.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $63.4M |
| 净利润 | — | $-1.8M |
| 毛利率 | 69.3% | 72.7% |
| 营业利润率 | 22.7% | -3.4% |
| 净利率 | — | -2.9% |
| 营收同比 | 27.7% | 17.0% |
| 净利润同比 | — | 72.5% |
| 每股收益（稀释后） | $0.26 | $-0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIWEAV
| Q4 25 | $75.5M | $63.4M | ||
| Q3 25 | $54.5M | $61.3M | ||
| Q2 25 | $52.4M | $58.5M | ||
| Q1 25 | $46.0M | $55.8M | ||
| Q4 24 | $59.1M | $54.2M | ||
| Q3 24 | $80.5M | $52.4M | ||
| Q2 24 | $47.1M | $50.6M | ||
| Q1 24 | $43.8M | $47.2M |
净利润PBYIWEAV
| Q4 25 | — | $-1.8M | ||
| Q3 25 | $8.8M | $-8.7M | ||
| Q2 25 | $5.9M | $-8.7M | ||
| Q1 25 | $3.0M | $-8.8M | ||
| Q4 24 | — | $-6.7M | ||
| Q3 24 | $20.3M | $-5.9M | ||
| Q2 24 | $-4.5M | $-8.6M | ||
| Q1 24 | $-4.8M | $-7.2M |
毛利率PBYIWEAV
| Q4 25 | 69.3% | 72.7% | ||
| Q3 25 | 77.7% | 72.3% | ||
| Q2 25 | 76.5% | 71.7% | ||
| Q1 25 | 77.1% | 71.6% | ||
| Q4 24 | 76.4% | 72.1% | ||
| Q3 24 | 63.9% | 72.0% | ||
| Q2 24 | 77.4% | 71.4% | ||
| Q1 24 | 75.5% | 69.9% |
营业利润率PBYIWEAV
| Q4 25 | 22.7% | -3.4% | ||
| Q3 25 | 17.6% | -14.6% | ||
| Q2 25 | 12.7% | -17.4% | ||
| Q1 25 | 8.7% | -16.7% | ||
| Q4 24 | 22.6% | -13.6% | ||
| Q3 24 | 27.4% | -12.7% | ||
| Q2 24 | -4.6% | -18.3% | ||
| Q1 24 | -5.3% | -17.3% |
净利率PBYIWEAV
| Q4 25 | — | -2.9% | ||
| Q3 25 | 16.2% | -14.1% | ||
| Q2 25 | 11.2% | -14.9% | ||
| Q1 25 | 6.5% | -15.8% | ||
| Q4 24 | — | -12.4% | ||
| Q3 24 | 25.2% | -11.2% | ||
| Q2 24 | -9.6% | -16.9% | ||
| Q1 24 | -11.0% | -15.3% |
每股收益（稀释后）PBYIWEAV
| Q4 25 | $0.26 | $-0.03 | ||
| Q3 25 | $0.17 | $-0.11 | ||
| Q2 25 | $0.12 | $-0.11 | ||
| Q1 25 | $0.06 | $-0.12 | ||
| Q4 24 | $0.40 | $-0.10 | ||
| Q3 24 | $0.41 | $-0.08 | ||
| Q2 24 | $-0.09 | $-0.12 | ||
| Q1 24 | $-0.10 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $55.0M |
| 总债务越低越好 | $22.7M | — |
| 股东权益账面价值 | $130.3M | $82.4M |
| 总资产 | $216.3M | $208.0M |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资PBYIWEAV
| Q4 25 | $97.5M | $55.0M | ||
| Q3 25 | $94.4M | $64.4M | ||
| Q2 25 | $96.0M | $44.7M | ||
| Q1 25 | $93.2M | $53.4M | ||
| Q4 24 | $101.0M | $51.6M | ||
| Q3 24 | $96.7M | $51.1M | ||
| Q2 24 | $96.8M | $51.7M | ||
| Q1 24 | $107.2M | $30.6M |
总债务PBYIWEAV
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益PBYIWEAV
| Q4 25 | $130.3M | $82.4M | ||
| Q3 25 | $115.3M | $78.6M | ||
| Q2 25 | $104.7M | $78.9M | ||
| Q1 25 | $97.1M | $68.6M | ||
| Q4 24 | $92.1M | $67.0M | ||
| Q3 24 | $71.1M | $68.8M | ||
| Q2 24 | $48.5M | $69.8M | ||
| Q1 24 | $51.0M | $73.4M |
总资产PBYIWEAV
| Q4 25 | $216.3M | $208.0M | ||
| Q3 25 | $202.9M | $206.5M | ||
| Q2 25 | $194.9M | $204.3M | ||
| Q1 25 | $196.2M | $188.3M | ||
| Q4 24 | $213.3M | $188.9M | ||
| Q3 24 | $220.7M | $192.0M | ||
| Q2 24 | $205.0M | $191.2M | ||
| Q1 24 | $214.1M | $190.2M |
负债/权益比PBYIWEAV
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $6.2M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $5.1M |
| 自由现金流率自由现金流/营收 | 19.1% | 8.1% |
| 资本支出强度资本支出/营收 | 0.0% | 1.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | $15.2M |
8季度趋势，按日历期对齐
经营现金流PBYIWEAV
| Q4 25 | $14.4M | $6.2M | ||
| Q3 25 | $9.7M | $6.1M | ||
| Q2 25 | $14.1M | $5.4M | ||
| Q1 25 | $3.6M | $-219.0K | ||
| Q4 24 | $15.6M | $6.7M | ||
| Q3 24 | $11.0M | $4.5M | ||
| Q2 24 | $1.0M | $22.7M | ||
| Q1 24 | $11.2M | $-19.7M |
自由现金流PBYIWEAV
| Q4 25 | $14.4M | $5.1M | ||
| Q3 25 | $9.7M | $5.8M | ||
| Q2 25 | $14.1M | $4.9M | ||
| Q1 25 | $3.6M | $-663.0K | ||
| Q4 24 | $15.6M | $6.3M | ||
| Q3 24 | $11.0M | $4.0M | ||
| Q2 24 | $1.0M | $21.9M | ||
| Q1 24 | — | $-20.2M |
自由现金流率PBYIWEAV
| Q4 25 | 19.1% | 8.1% | ||
| Q3 25 | 17.7% | 9.4% | ||
| Q2 25 | 26.8% | 8.4% | ||
| Q1 25 | 7.7% | -1.2% | ||
| Q4 24 | 26.4% | 11.6% | ||
| Q3 24 | 13.7% | 7.5% | ||
| Q2 24 | 2.1% | 43.4% | ||
| Q1 24 | — | -42.9% |
资本支出强度PBYIWEAV
| Q4 25 | 0.0% | 1.8% | ||
| Q3 25 | 0.0% | 0.5% | ||
| Q2 25 | 0.0% | 0.9% | ||
| Q1 25 | 0.1% | 0.8% | ||
| Q4 24 | 0.0% | 0.7% | ||
| Q3 24 | 0.0% | 1.0% | ||
| Q2 24 | 0.0% | 1.5% | ||
| Q1 24 | 0.0% | 1.1% |
现金转化率PBYIWEAV
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
